Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
October 2, 2003
[CD95 resistance and Fas ligand synthesis as mechanism of defense by immunocompetent cells in pancreatic tumors]
H Ungefroren, M Voss, D Henne-Bruns, et al.
Stem Cells (Dayton, Ohio)
|
July 2, 2003
Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages
Maren Ruhnke, H Ungefroren, G Zehle, et al.
Molecular Human Reproduction
|
June 1, 1997
Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis
R Ivell, M Balvers, R Domagalski, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Immunological escape mechanisms in pancreatic carcinoma
H Ungefroren, M Voss, W V Bernstorff, et al.
Cancer Research
|
May 1, 1998
Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
H Ungefroren, M Voss, M Jansen, et al.
FEBS Letters
|
April 20, 2001
Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells
O Grobe, A Arlt, H Ungefroren, et al.
Advances in Biochemical Engineering/Biotechnology
|
September 1, 2012
Adult mesenchymal stem cells explored in the dental field
K M Fawzy El-Sayed, C Dörfer, F Fändrich, et al.
International Journal of Oncology
|
December 24, 1998
TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression
M Voss, B Wolff, N Savitskaia, et al.
Oncogene
|
February 14, 2007
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function
B Schniewind, S Groth, S Sebens Müerköster, et al.
The Journal of Endocrinology
|
January 1, 1994
Over-expression of oxytocin in the testes of a transgenic mouse model
H L Ang, R Ivell, N Walther, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
October 2, 2003
[CD95 resistance and Fas ligand synthesis as mechanism of defense by immunocompetent cells in pancreatic tumors]
H Ungefroren, M Voss, D Henne-Bruns, et al.
Stem Cells (Dayton, Ohio)
|
July 2, 2003
Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages
Maren Ruhnke, H Ungefroren, G Zehle, et al.
Molecular Human Reproduction
|
June 1, 1997
Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis
R Ivell, M Balvers, R Domagalski, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Immunological escape mechanisms in pancreatic carcinoma
H Ungefroren, M Voss, W V Bernstorff, et al.
Cancer Research
|
May 1, 1998
Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
H Ungefroren, M Voss, M Jansen, et al.
FEBS Letters
|
April 20, 2001
Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells
O Grobe, A Arlt, H Ungefroren, et al.
Advances in Biochemical Engineering/Biotechnology
|
September 1, 2012
Adult mesenchymal stem cells explored in the dental field
K M Fawzy El-Sayed, C Dörfer, F Fändrich, et al.
International Journal of Oncology
|
December 24, 1998
TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression
M Voss, B Wolff, N Savitskaia, et al.
Oncogene
|
February 14, 2007
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function
B Schniewind, S Groth, S Sebens Müerköster, et al.
The Journal of Endocrinology
|
January 1, 1994
Over-expression of oxytocin in the testes of a transgenic mouse model
H L Ang, R Ivell, N Walther, et al.
Page
of 3